HAVCR2 and cervical cancer: The Tim-3-Gal-9 pathway activation encourages Treg cells to release TGF-β and IL-10, which suppresses the cytotoxic activity of Th1 and CD8 T cells, thus facilitating immune evasion by cervical cancer cells.